Prognostic Factors in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer: A Systematic Literature Review.

Gebra Cuyún CarterMaitreyee MohantyKeri StengerClaudia Morato Guimaraes Shivaprasad Singuru Pradeep BasaSheena SinghVanita TongbramSherko KuemmelValentina GuarneriSara M Tolaney

Published in: Cancer management and research (2021)

Multiple disease, treatment, and patient-related prognostic factors impact survival, particularly OS, in patients with HR+/HER2- advanced breast cancer. Treatment outcomes can vary considerably due to these factors. Understanding poorer prognostic factors for patients can result in improved clinical decision-making.

Keyphrases

prognostic factors
epidermal growth factor receptor
decision making
tyrosine kinase
advanced non small cell lung cancer
endothelial cells
case report
ejection fraction
young adults
newly diagnosed
induced pluripotent stem cells
free survival
pluripotent stem cells